Brief: Blue Vision FY Net Loss Widens To DKK 32.9 Mln
April 1 (Reuters) - Blue Vision A/S BLVISa.CO :
* REPORTED ON WEDNESDAY FY NET LOSS DKK 32.9 MLN VS LOSS DKK
14.4
MLN YR AGO
* BEFORE IMPLEMENTING NEW INVESTMENT STRATEGY AND ADDING NEW
BUSINESS, MANAGEMENT EXPECTS LIMITED NEGATIVE OPERATING RESULT
FOR 2021
Source text: https://bit.ly/3m7bm54
Further company coverage: BLVISa.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))
Recent news on Pharma Equity A/S
See all newsBrief: PEG: Interpatium Commences Proceedings To Set Aside Arbitral Award
Brief: Pharma Equity Maintains Financial Guidance For 2026
Brief: Pharma Equity Group Unit Gets Patent Grant Notification
Brief: Pharma Equity Group To Borrow Up To About DKK 9.63 Million
Brief: Pharma Equity Group Adjusts 2025 Expectations